Analysis | Metabolite Name | Measured Value | Units | Drug combination | 13C-label position in pyruvate |
---|---|---|---|---|---|
ESI/QTOF negative ion mode | Aspartate | 1071703 | Peak area | Isoproterenol + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate | 1107433 | Peak area | Isoproterenol + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate | 1351105 | Peak area | Rosiglitazone + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate | 1546595 | Peak area | Rosiglitazone + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate | 1720892 | Peak area | Isoproterenol | C1 |
ESI/QTOF negative ion mode | Aspartate | 1817803 | Peak area | Isoproterenol | C2 |
ESI/QTOF negative ion mode | Aspartate | 1865306 | Peak area | Rosiglitazone | C1 |
ESI/QTOF negative ion mode | Aspartate | 2170392 | Peak area | Rosiglitazone | C2 |
ESI/QTOF negative ion mode | Aspartate | 2296101 | Peak area | None | C1 |
ESI/QTOF negative ion mode | Aspartate | 2672124 | Peak area | None | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 84275.86 | Peak area | Isoproterenol + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 120534.75 | Peak area | Rosiglitazone + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 190082.18 | Peak area | Isoproterenol + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 215165.75 | Peak area | Isoproterenol | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 235176.6 | Peak area | Rosiglitazone | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 253718 | Peak area | Rosiglitazone + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 300762.34 | Peak area | None | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 399558.07 | Peak area | Isoproterenol | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 492147.59 | Peak area | Rosiglitazone | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_1 | 554526.32 | Peak area | None | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 285.14388 | Peak area | Isoproterenol + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 735.19769 | Peak area | Rosiglitazone + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 3260.5001 | Peak area | Rosiglitazone | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 5287.673 | Peak area | None | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 6748.5455 | Peak area | Isoproterenol | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 10121.736 | Peak area | Isoproterenol + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 10160.84 | Peak area | Rosiglitazone + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 12014.433 | Peak area | Rosiglitazone | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 13161.803 | Peak area | Isoproterenol | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_2 | 13387.738 | Peak area | None | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_3 | 151.77764 | Peak area | Rosiglitazone + Leelamine | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_3 | 395.7194 | Peak area | None | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_3 | 1395.6236 | Peak area | None | C1 |
ESI/QTOF negative ion mode | Aspartate_13C_3 | 2432.8882 | Peak area | Rosiglitazone + Leelamine | C2 |
ESI/QTOF negative ion mode | Aspartate_13C_3 | Peak area | Isoproterenol | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_3 | Peak area | Isoproterenol | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_3 | Peak area | Isoproterenol + Leelamine | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_3 | Peak area | Isoproterenol + Leelamine | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_3 | Peak area | Rosiglitazone | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_3 | Peak area | Rosiglitazone | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Isoproterenol | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Isoproterenol | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Isoproterenol + Leelamine | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Isoproterenol + Leelamine | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | None | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | None | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Rosiglitazone | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Rosiglitazone | C2 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Rosiglitazone + Leelamine | C1 | |
ESI/QTOF negative ion mode | Aspartate_13C_4 | Peak area | Rosiglitazone + Leelamine | C2 |